SQUAWK/NEWS
Menu
Live News EQUITY L impact

Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84

Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84

ASXMYX
SQUAWKNEWS Updated Jul 03, 2026, 10:55 AM UTC

Canaccord Genuity Downgrades Mayne Pharma Group to Speculative Buy From Buy; Price Target is AU$3.84.